# NUCALA
> **BLA125526** · Biologics License Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2015-11-04
## Drug
- **FDA Application Number:** BLA125526
- **Application type:** Biologics License Application
- **Brand name:** NUCALA
- **Generic name:** MEPOLIZUMAB
- **Active ingredients:** MEPOLIZUMAB
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS LYOPHILIZED POWER
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE LLC
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2015-11-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125526)
---
*AI Analytics · CC0 1.0*